Department of Plastic Surgery, European Georges Pompidou Hospital, AP-HP, Paris, France.
Innovative Therapies in Haemostasis, INSERM UMR-S 1140, University of Paris, F-75006, Paris, France.
Stem Cell Rev Rep. 2023 Aug;19(6):1726-1754. doi: 10.1007/s12015-023-10568-4. Epub 2023 Jun 1.
Autologous fat transplantation -i.e., lipofilling- has become a promising and popular technique in aesthetic and reconstructive surgery with several application such as breast reconstruction, facial and hand rejuvenation. However, the use of this technology is still limited due to an unpredictable and low graft survival rate (which ranges from 25%-80%). A systematic literature review was performed by thoroughly searching 12 terms using the PubMed database. The objective of this study is to present the current evidence for the efficacy of adjuvant regenerative strategies and cellular factors, which have been tested to improve fat graft retention. We present the main results (fat retention rate, histological analysis for pre-clinical studies and satisfaction/ complication for clinical studies) obtained from the studies of the three main fat grafting enrichment techniques: platelet-rich plasma (PRP), the stromal vascular fraction (SVF) and adipose-derived stem cells (ADSCs) and discuss the promising role of recent angiogenic cell enrichment that could induce early vascularization of fat graft. All in all, adding stem or progenitor cells to autologous fat transplantation might become a new concept in lipofilling. New preclinical models should be used to find mechanisms able to increase fat retention, assure safety and transfer these technologies to a good manufacturing practice (GMP) compliant facility, to manufacture an advanced therapy medicinal product (ATMP).
自体脂肪移植——即脂肪填充——已成为美容和重建外科领域一项有前途且受欢迎的技术,其应用广泛,如乳房重建、面部和手部年轻化等。然而,由于移植物存活率不可预测且较低(25%-80%),该技术的应用仍受到限制。本研究通过全面检索 PubMed 数据库中的 12 个术语进行了系统的文献回顾。本研究的目的是介绍目前已证实的可提高脂肪移植成活率的辅助再生策略和细胞因子的有效性。我们介绍了三种主要脂肪移植富集技术(富血小板血浆 [PRP]、基质血管成分 [SVF] 和脂肪来源干细胞 [ADSCs])的主要研究结果(脂肪保留率、临床前研究的组织学分析以及临床研究的满意度/并发症),并讨论了最近的血管生成细胞富集的有前途的作用,该作用可诱导脂肪移植的早期血管化。总之,将干细胞或祖细胞添加到自体脂肪移植中可能成为脂肪填充的新概念。应使用新的临床前模型来寻找能够提高脂肪保留率、确保安全性并将这些技术转移到符合良好生产规范(GMP)的设施中以制造先进治疗药物产品(ATMP)的机制。